Medidata Solutions, Inc.

Medidata Solutions, Inc. is an American technology company headquartered in New York City, NY, that develops and markets software as a service (SaaS) for clinical trials. Its core mission is to lead the digital transformation of life sciences, creating hope for millions of patients by helping pharmaceutical, biotech, medical device, and diagnostics companies, as well as academic researchers, accelerate value, minimize risk, and optimize outcomes. The company aims to power smarter treatments and healthier people globally.

Medidata offers a unified, cloud-based platform that addresses the entire clinical research process, from study design to data management and analysis. Key products include Medidata Rave EDC for electronic data capture and Medidata Rave Clinical Cloud for managing patient-related data. The company provides "Experiences" such as Patient Experience, Data Experience, and Study Experience, which leverage AI and automation to streamline workflows and improve data quality. Medidata serves a broad market segment including biopharmaceutical, medical device, and diagnostics companies, government institutions, contract research organizations (CROs), and academic researchers.

As a brand of Dassault Systèmes since its acquisition in 2019, Medidata continues to be a leader in clinical trial solutions. In August 2025, Lisa Moneymaker was appointed Chief Strategy Officer to drive product innovation and AI-driven clinical trial experiences. Medidata is a trusted partner to many top pharmaceutical companies, having added over 300 new customers in 2024, and is recognized for its patient-centric approach and its extensive historical clinical trial data set.